Your Search Returned 1 tagged news report
The approval of Sanofi-Aventis’s Aubagio drug by the FDA (Food and Drug Administration) for treatment of relapsing forms of Multiple Sclerosis (MS) in adults is regarded to be one of the most significant clinical aspects of the drug
Tags: